Research
Hormonal
Semaglutide 2.4 mg was associated with significantly greater weight loss compared to placebo in clinical trials lasting 68 weeks.
Semaglutide can be considered an effective pharmacotherapy for weight loss in adults with obesity or overweight.
StrongSupportsmedium confidence
In these 68-week trials, semaglutide 2.4 mg was associated with significantly greater weight loss compared to placebo.
Why this rating
Based on the mention of clinical trials, which are high-quality evidence.
Source
Semaglutide for Weight Loss: Was It Worth the Weight?
Joel Novograd et al. · Cardiology in Review · 2022
reviewCited 14×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →